We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Verenium Announces Organizational Change

The Company strengthens research and development organization, including the pilot and demonstration-scale biofuels operations in Jennings, Louisiana.
News

Zosano Pharma Presents Positive Phase 2 Results of Its Needle-Free Osteoporosis Therapy

Rapid delivery transdermal patch demonstrates increase in lumbar spine and hip bone mineral density.
News

Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer

Discovery could lead to the development of a next-generation assay to improve diagnosis and treatment of ovarian cancer.
News

Alnylam Initiates Phase I Clinical Study of ALN-VSP in Patients with Liver Cancer

ALN-VSP Represents Company’s First Clinical Program with a Systemically Delivered RNAi Therapeutic.
News

Building a Better Cell Culture System

HHMI researchers creates “intelligent scaffold” for growing human cells that can mimic conditions inside the body better than the standard.
News

NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative Host Nanoweek 2009

The NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative will host NanoWeek 2009 from Tuesday, April 7 through Friday, April 10 at the Natcher Conference Center on the NIH campus in Bethesda, Md.
News

Genome Sequencer FLX System Installed at University of Barcelona

The Genome Sequencer FLX will be installed at the Genomics Unit of the Scientific and Technical Services at UB.
News

Compugen Announces Inhibition of Angiogenesis by Novel Peptide

CGEN-25017 peptide antagonist of the Angiopoietin/Tie-2 pathway was predicted using Compugen’s DAC blockers discovery platform.
News

Horizon Discovery Sign Three-Year Collaboration with Genentech

Horizon’s GENESIS™ platform to develop genetically-defined human ‘X-MAN’ cancer models for deployment in Genentech’s research programs.
News

InterMed Discovery Announces Collaboration Agreement with the Lead Discovery Center

Collaboration focuses identifying naturally derived modulators by screening IMD’s natural product libraries against targets provided by LDC.
Advertisement